These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-005244-28 Pilotstudie zur Therapieoptimierungsstudie für den Morbus Hodgkin bei Kindern und Jugendlichen Prüfung der Verträglichkeit der Chemotherapiekombination VECOPA bei Patienten der Therapiegruppen 2 und... 2013-08-31 due-trials
Reported results Terminated 2005-003166-42 Palliative Chemotherapy (2nd line) with Imatinib (GlivecTM) in Patients with Bile Duct Cancer. 2009-08-31 due-trials
Completed, but no date, and reported results 2005-003943-30 Doubleblind randomized multicenter trial to investigate the influence of dimenhydrinate suppositories vs. placebo on oral rehydration in infants and children with infectious enteritis and vomiting bad-data
Reported results 2005-005987-94 Double-blind placebo-controlled randomised trial of lamivudine in the treatment of acute hepatitis B 2009-12-08 due-trials
Reported results 2006-004224-37 Everolimus in der Therapie von Patienten mit pulmonaler Hypertonie 2009-11-05 due-trials
Not reported 2006-006091-38 Randomisierte Phase II Screeningstudie zum Einsatz einer TP/TPF-Chemotherapie (Kurzinduktion) vor TP/TPF-Induktion, Radiotherapie mit und ohne Cetuximab in der Primärtherapie des nur durch Laryngektom... 2015-08-25 due-trials
Reported results 2006-006465-16 Pilot trial of recombinant human growth hormone for remyelination in multiple sclerosis 2016-03-15 due-trials
Exempt 2007-001194-29 An open-label, multi-center Phase I/II trial evaluating the safety and efficacy of azacitidine (Vidaza®) in patients with acute myeloid leukaemia not eligible for or resistant to chemotherapy not-yet-due
Reported results Terminated 2007-001744-53 Open, randomized study for evaluation of an active Hepatitis B vaccination(HBVAXPRO) in combination with a passive immunisation with Hepatitis B immunoglobulins (Hepatect) for subjects, who did not sh... 2010-03-09 due-trials
Reported results Terminated 2007-001888-29 Chronic inflammatory activation in fat tissue: an atherogenic factor in severe coronary artery disease. 2012-07-27 due-trials
Completed, but no date 2007-002420-15 Phase II-Studie zur Effizienz der vorzeitigen Reduktion von CSA/MMF bei fallendem linienspezifischen Chimärismus nach allogener Stammzelltransplantation nach Konditionierung mit low-dose TBI/Fludara... bad-data
Reported results 2007-004790-25 Evaluation of the benefit of fluorescence diagnostics using Metvix® and the Dyaderm system for the preoperational estimation of the lateral tumour spread in basal cell carcinomas. 2008-11-03 due-trials
Reported results 2007-004979-19 In-vivo assessment of nicotinic acetylcholine receptor binding in neurodegenerative diseases using the radioligand 2-[18F]FA-85380 and positron emission tomography (PET) 2016-11-01 due-trials
Reported results 2007-007864-63 Prospective, randomized and controlled clinical trial comparing i.v. bolus application of Abciximab to i.c.application of Abciximab during primary PCU in patients with acute ST-elevation myocardial in... 2012-06-11 due-trials
Reported results 2007-007970-47 Central nervous effects of exendin-4 on hunger and satiety in obesity and diabetes mellitus type 2: an fMRI study 2012-07-01 due-trials
Exempt 2008-001885-96 Treatment with Lenalidomide, Bendamustine and Prednisone (RBP) in Patients with Relapsed or Refractory Multiple Myeloma after Autologous Stem Cell Transplantation or Conventional Chemotherapy OSHO #07... 2016-09-26 not-yet-due
Reported results 2008-003064-19 Phase-IIb-Study to Evaluate the Effect of a Neoadjuvant Chemotherapy with Docetaxel, Epirubicine and Cyclphosphamide (TEC) in Patients with primary HER-2 neu Negative Mammacarcinoma Phase-IIb-Stud... 2016-07-07 due-trials
Reported results 2009-011737-27 A multi centre randomised placebo-controlled double-blind clinical trial for the evaluation of efficacy of specific immunotherapy with an aluminium hydroxide-adsorbed recombinant hypoallergenic deriva... 2014-07-18 due-trials
Reported results 2009-015749-22 A prospective, monocentric clinical trial with adalimumab for topical treatment in chronic wounds 2012-11-30 due-trials
Reported results Terminated 2009-017347-33 A multicenter Phase I/II trial investigating the safety and efficacy (CR rate and OS) of low dose AraC with Clofarabine in patients ≥60 years with AML not eligible for conventional Chemotherapy 2013-08-24 due-trials
Reported results 2010-020403-75 ACE inhibitor for lung protection during mechanical Ventilation for acute lung injury - pilot trial ACE-Hemmer zur Lungenprotektion bei beatmeten Patienten mit akutem Lungenversagen - Pilotstudie 2016-01-17 due-trials
Reported results 2010-020441-27 Ranibizumab combined with selective peripheral laser photocoagulation for treatment of central retinal vein occlusion A randomized, controlled interventional phase 2b (proof of concept) study of of t... 2012-09-25 due-trials
Reported results 2010-022057-42 Pilot study to optimise the use and to evaluate the diagnostic value of intraoperative contrast-enhanced 3D-ultrasound with SonoVue® for imaging of intracranial tumors Pilotstudie zur Optimierung d... 2013-12-23 due-trials
Exempt, with results 2010-023584-17 Response-Adapted Sequential Azacitidine And Chemotherapy in Patients > 60 Years Old With Newly Diagnosed AML Eligible for Chemotherapy and allogeneic hematopoietic cell transplantation: A Multicentre ... 2018-05-25 not-yet-due
Reported results 2010-023992-24 International randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate 2016-02-08 due-trials
Reported results 2012-004383-22 Perioperative complications in obese and non-obese patients: Prevention and treatment of wound infections and post-operative pain. Prospective, open, monocentric study to investigate perioperative tis... 2017-03-21 due-trials
Reported results 2012-004442-15 High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients bei... 2014-03-03 due-trials
Reported results 2012-005439-10 Re-treatment with intravitreal application of ranibizumab guided by morphological macular changes documented by optical coherence tomography (OCT) in patients with macular edema due to branch retinal ... 2016-05-17 due-trials
Reported results Terminated 2013-004353-24 Wound Management in Post-Bariatric Surgery Investigation for the reduction of the mean drainage volume in patients after abdominoplasty / lower body lift using Artiss Fibrin Sealant in comparison to t... 2017-03-03 due-trials
Completed, but no date, and reported results 2013-004882-15 A multicentre randomized controlled trial evaluating the rate of sustained remission and the safety when stopping nucleos(t)ide analogue treatment in non-cirrhotic HBeAg-negative chronic Hepatitis B p... bad-data
Exempt, with results 2014-000346-30 An open-label, multicenter study of INC424 monotherapy or in combination with azacitidine for patients with post-myeloproliferative disorders (MPD) – AML or with CMML Eine offene, multizentrische S... 2018-11-28 not-yet-due
Reported results 2015-000488-15 Vigilance regulation as predictor of response to Psychostimulants in adult patients with ADHD Vigilanzregulation als Prädiktor der Response auf Psychostimulanzien bei adulten Patienten mit ADHS 2018-08-16 due-trials
Reported results 2015-002212-32 Granulocyte colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicentre randomized Trial 2020-03-17 due-trials
Ongoing 2017-000635-13 Escalating therapy in steroid-refractory relapses of multiple sclerosis – comparison of methylprednisolone to immunoadsorption Eskalationstherapie des MS-Schubs mit Methylprednisolon vs. Immunadsor... not-yet-due
Ongoing 2017-002546-74 Postoperative adjuvant radiochemotherapy (aRCH) with Cisplatin (C) versus aRCH with C and Pembrolizumab (P) in locally advanced head and neck squamous cell carcinoma (HNSCC); multicenter randomized Ph... not-yet-due
Ongoing 2019-004126-13 Cabozantinib treatment in a phase II study for patients with hepatocellular carcinoma (HCC) refractory to PD-1 or PD-L1 inhibitors Cabozantinib-Behandlung in einer Phase-II-Studie für Patienten mit... not-yet-due
Completed, but no date, and reported results 2019-004536-37 Treatment of MDS/AML patients with an impending hematological relapse with azacitidine alone or in combination with pevonedistat - a randomized phase 2 trial Behandlung von MDS und AML Patienten mi... bad-data
Ongoing 2020-000624-20 Core decompression versus core decompression followed by infusion of Iloprost in the treatment of non-traumatic avascular necrosis of the femoral head not-yet-due
Ongoing 2020-003986-20 A Phase II, Open-Label, Multicenter Study of Orally Administered CA-4948 for the Treatment of Anemia in Patients with Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) Eine offene ... not-yet-due